According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โฌ13.48 Billion. In 2023 the company made an earning of โฌ3.87 Billion a decrease over its 2022 earnings that were of โฌ4.48 Billion. The earnings displayed on this page is the company's Pretax Income.